Sphere culture significantly enriched the subpopulation of CD44+/CD24−/low/EpCAM+ cells, supporting the hypothesis that CD44+/CD24−/low/EpCAM+ cells are a more selective cancer stem cell subpopulation than CD44+/CD24−/low cells in triple-negative breast cancer. The gene discussed is CD44; the disease is triple-negative breast carcinoma.